146 related articles for article (PubMed ID: 2362000)
1. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine.
Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA
J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000
[No Abstract] [Full Text] [Related]
2. Isolation and determination of the diastereomers of the glucuronidated 5-(4-hydroxyphenyl)-5-phenylhydantoin in human urine using HPLC.
Hermansson J; Iversen T; Lindquist U
Acta Pharm Suec; 1982; 19(3):199-210. PubMed ID: 7113727
[No Abstract] [Full Text] [Related]
3. Sensitive method for the determination of phenytoin in plasma, and phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in urine by high-performance liquid chromatography.
Maya MT; Farinha AR; Lucas AM; Morais JA
J Pharm Biomed Anal; 1992; 10(10-12):1001-6. PubMed ID: 1298355
[TBL] [Abstract][Full Text] [Related]
4. Liquid-chromatographic method for simultaneous determination of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in plasma and urine.
Sawchuk RJ; Cartier LL
Clin Chem; 1980 Jun; 26(7):835-9. PubMed ID: 7379305
[TBL] [Abstract][Full Text] [Related]
5. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
Thompson RM; Beghin J; Fife WK; Gerber N
Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
[TBL] [Abstract][Full Text] [Related]
6. High-pressure liquid-chromatographic determination of 5-(4-hydroxyphenyl)-5-phenylhydantoin in humanurine.
Kabra PM; Marton LJ
Clin Chem; 1976 Oct; 22(10):1672-4. PubMed ID: 975513
[TBL] [Abstract][Full Text] [Related]
7. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
Maguire JH
Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
[TBL] [Abstract][Full Text] [Related]
8. A gas chromatographic/mass spectrometric method for the simultaneous quantitation of 5,5-diphenylhydantoin (phenytoin), its para-hydroxylated metabolite and their stable isotope labelled analogs.
Van Langenhove A; Costello CE; Biller JE; Biemann K; Browne TR
Clin Chim Acta; 1981 Sep; 115(3):263-75. PubMed ID: 7028323
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic determination of the major metabolite of phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin in human urine.
Moustafa MA; Belal F; el-Emam AA
J Pharm Belg; 1987; 42(1):53-8. PubMed ID: 3585688
[No Abstract] [Full Text] [Related]
10. High-performance liquid chromatographic method for direct separation of 5-(p-hydroxyphenyl)-5-phenylhydantoin enantiomers using a chiral tris(4-methylbenzoate) column.
Eto S; Noda H; Noda A
J Chromatogr; 1991 Jul; 568(1):157-63. PubMed ID: 1770093
[TBL] [Abstract][Full Text] [Related]
11. Protein binding of phenytoin, p-hydroxy phenytoin, and p-hydroxy phenytoin glucuronide.
Matzke GR; Brundage RC; Sawchuk RJ
J Clin Pharmacol; 1986; 26(8):677-9. PubMed ID: 3793960
[No Abstract] [Full Text] [Related]
12. Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.
Atkinson AJ; MacGee J; Strong J; Garteiz D; Gaffney TE
Biochem Pharmacol; 1970 Aug; 19(8):2483-91. PubMed ID: 5520606
[No Abstract] [Full Text] [Related]
13. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
[TBL] [Abstract][Full Text] [Related]
14. Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapy.
Rambeck B; May T
Ther Drug Monit; 1984; 6(2):164-72. PubMed ID: 6740735
[TBL] [Abstract][Full Text] [Related]
15. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
[TBL] [Abstract][Full Text] [Related]
16. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic determination of phenytoin and hydroxyphenytoin in human urine.
Sato A; Shimada K; Izumo Y; Sakaguchi T
J Chromatogr; 1983 Jun; 275(1):97-105. PubMed ID: 6874875
[TBL] [Abstract][Full Text] [Related]
18. Urinary dihydrodiol metabolites of phenytoin: high-performance liquid chromatographic assay of diastereomeric composition.
Maguire JH; Wilson DC
J Chromatogr; 1985 Aug; 342(2):323-32. PubMed ID: 4055953
[TBL] [Abstract][Full Text] [Related]
19. Quantification of phenytoin and its metabolites in equine plasma and urine using high-performance liquid chromatography.
Guan F; Uboh CE; Soma LR; Birks EK; Teleis D; Rudy JA; Watson AO; Tsang DS
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):209-18. PubMed ID: 11076073
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography.
Chang T; Glazko AJ
J Lab Clin Med; 1970 Jan; 75(1):145-55. PubMed ID: 5410494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
